Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Non-Current Debt (2020 - 2025)

Rapid Micro Biosystems' Non-Current Debt history spans 3 years, with the latest figure at $18.9 million for Q4 2025.

  • On a quarterly basis, Non-Current Debt changed N/A to $18.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.9 million, a N/A change, with the full-year FY2025 number at $18.9 million, changed N/A from a year prior.
  • Non-Current Debt hit $18.9 million in Q4 2025 for Rapid Micro Biosystems, roughly flat from $18.8 million in the prior quarter.
  • Over the last five years, Non-Current Debt for RPID hit a ceiling of $25.0 million in Q2 2021 and a floor of $18.8 million in Q3 2025.